Cancer Cachexia Market is segmented By Drug (Anabolic Steroids, Anti-inflammatory Drugs), By Route o...
Market Size in USD Bn
CAGR6.6%
Study Period | 2025-2032 |
Base Year of Estimation | 2024 |
CAGR | 6.6% |
Market Concentration | High |
Major Players | Helsinn Therapeutics, Actimed Therapeutics, Pfizer, Aveo Oncology, Artelo Biosciences and Among Others |
The cancer cachexia market is estimated to be valued at USD 2.84 Bn in 2025 and is expected to reach USD 4.44 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.6% from 2025 to 2032. Rising awareness among patients and healthcare professionals regarding management of cancer related weight loss is expected to boost the demand. Moreover, development and commercialization of novel drugs and therapies for cachexia indication will further support the market growth through 2032.